Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease

Synuclein gamma (SNCG) expression is associated with advanced disease and chemoresistance in multiple solid tumors. Our goal was to determine if SNCG protein expression in ovarian cancer was correlated with clinicopathologic variables and patient outcomes. Tissue microarrays from primary tumors of 3...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of ovarian research 2016-11, Vol.9 (1), p.75-75, Article 75
Hauptverfasser:	Strohl, Anna, Mori, Kristina, Akers, Stacey, Bshara, Wiam, Buttin, Barbara, Frederick, Peter J, Helenowski, Irene B, Morrison, Carl D, Odunsi, Kunle, Schink, Julian C, Scholtens, Denise M, Wei, Jian-Jun, Kim, J Julie
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Biomarkers, Tumor Drug Resistance, Neoplasm - genetics Female Follow-Up Studies gamma-Synuclein - genetics gamma-Synuclein - metabolism Gene Expression Humans Kaplan-Meier Estimate Middle Aged Neoplasm Grading Neoplasm Metastasis Neoplasm Staging Ovarian Neoplasms - diagnosis Ovarian Neoplasms - drug therapy Ovarian Neoplasms - genetics Ovarian Neoplasms - mortality Prognosis Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!